VolitionRx Limited Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount
VolitionRx Limited (VNRX) had Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount of $165.47 thousand as of 2019-12-31, per its 10-K filed 2020-02-20.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions · last filed 2020-02-20
- 2019-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $165.47K.
- 2018-12-31: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $150.35K.
- 2018-09-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $647.90K.
- 2018-06-30: Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount $1.10M.
| Period end | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount |
|---|---|
| 2019-12-31 | $165.47K 10-K · filed 2020-02-20 |
| 2018-12-31 | $150.35K 10-K · filed 2019-03-13 |
| 2018-09-30 | $647.90K 10-Q · filed 2018-11-07 |
| 2018-06-30 | $1.10M 10-Q · filed 2018-08-13 |
| 2018-03-31 | $1.59M 10-Q · filed 2018-05-10 |
| 2017-12-31 | $553.41K 10-K · filed 2018-03-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |